Carolyn N. Krasner, M.D.

Publications

Campos SM, Berlin ST, Parker LM, Chen WY, Bunnell CA, Atkinson T, Lee J, Matulonis U, Hirsch MS, Harris L, Krasner CN.Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.Int
20405155
Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia FM, Pujade-Lauraine E, Lisyanskaya AS, Makhson AN, Rolski J, Gorbounova VA, Ghatage P, Bidzinski M, Shen K, Ngan HY, Vergote IB, Nam JH, Park YC, Lebedinsky CA, Poveda AM.Trabectedin Plus Pegyl
20516432
Roche MR, Rudd PJ, Krasner CN, Matulonis UA, Berlin ST, Lee H, Silver M, Tran CD, Seiden MV, Penson RT.Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.Gynecol Oncol. 2010 Feb;116(2):168-72.
19922985
Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM.Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for
19917843
Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT.Cediranib, an oral inhibitor of vascular endothelial gro
19826113
Miller DS, Blessing JA, Drake RD, Higgins R, McMeekin DS, Puneky LV, Krasner CN.A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncol
19804902
Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT.Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.J Allergy Clin Immunol. 2009 Jun;123(6):1262-7.e1.
19501233
Miller DS,Blessing JA,Krasner CN,Mannel RS,Hanjani P,Pearl ML,Waggoner SE,Boardman CH.Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Onco
19332726
Matulonis UA,Krag KJ,Krasner CN,Atkinson T,Horowitz NS,Lee H,Penson RT.Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors.Gynecol Oncol. 2009 Feb;112(2):394-9.
19058838
Matulonis UA,Horowitz NS,Campos SM,Lee H,Lee J,Krasner CN,Berlin S,Roche MR,Duska LR,Pereira L,Kendall D,Penson RT.Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.J Clin Oncol. 2008 Dec 10;26(3
19001330
Krasner CN, Roche M, Horowitz NS, Supko JG, Lee SI, Oliva E.Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.N Engl J Med. 2006 Apr 13;354(15):1615-25.
16611953

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	Carolyn N. Krasner, M.D. Publications Campos SM, Berlin ST, Parker LM, Chen WY, Bunnell CA, Atkinson T, Lee J, Matulonis U, Hirsch MS, Harris L, Krasner CN.Phase I trial of liposomal doxorubicin and ZD1839 in patients with refractory gynecological malignancies or metastatic breast cancer.Int 20405155 Monk BJ, Herzog TJ, Kaye SB, Krasner CN, Vermorken JB, Muggia FM, Pujade-Lauraine E, Lisyanskaya AS, Makhson AN, Rolski J, Gorbounova VA, Ghatage P, Bidzinski M, Shen K, Ngan HY, Vergote IB, Nam JH, Park YC, Lebedinsky CA, Poveda AM.Trabectedin Plus Pegyl 20516432 Roche MR, Rudd PJ, Krasner CN, Matulonis UA, Berlin ST, Lee H, Silver M, Tran CD, Seiden MV, Penson RT.Phase II trial of GM-CSF in women with asymptomatic recurrent müllerian tumors.Gynecol Oncol. 2010 Feb;116(2):168-72. 19922985 Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM.Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for 19917843 Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT.Cediranib, an oral inhibitor of vascular endothelial gro 19826113 Miller DS, Blessing JA, Drake RD, Higgins R, McMeekin DS, Puneky LV, Krasner CN.A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncol 19804902 Hesterberg PE, Banerji A, Oren E, Penson RT, Krasner CN, Seiden MV, Wong JT.Risk stratification for desensitization of patients with carboplatin hypersensitivity: clinical presentation and management.J Allergy Clin Immunol. 2009 Jun;123(6):1262-7.e1. 19501233 Miller DS,Blessing JA,Krasner CN,Mannel RS,Hanjani P,Pearl ML,Waggoner SE,Boardman CH.Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Onco 19332726 Matulonis UA,Krag KJ,Krasner CN,Atkinson T,Horowitz NS,Lee H,Penson RT.Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Mullerian tumors.Gynecol Oncol. 2009 Feb;112(2):394-9. 19058838 Matulonis UA,Horowitz NS,Campos SM,Lee H,Lee J,Krasner CN,Berlin S,Roche MR,Duska LR,Pereira L,Kendall D,Penson RT.Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.J Clin Oncol. 2008 Dec 10;26(3 19001330 Krasner CN, Roche M, Horowitz NS, Supko JG, Lee SI, Oliva E.Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis.N Engl J Med. 2006 Apr 13;354(15):1615-25. 16611953
Site Map Site Feedback Web Privacy Policy